Literature DB >> 1515799

Guidelines on the management of tuberculosis and HIV infection in the United Kingdom. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1515799      PMCID： PMC1881790          DOI： 10.1136/bmj.304.6836.1231

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

Review 1.  Tuberculosis in patients with human immunodeficiency virus infection.

Authors:  P F Barnes; A B Bloch; P T Davidson; D E Snider
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

Review 2.  Mycobacterium avium-intracellulare infection in the acquired immunodeficiency syndrome.

Authors:  A Scoular; P French; R Miller
Journal:  Br J Hosp Med       Date:  1991-11

3.  Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.

Authors:  J Hoy; A Mijch; M Sandland; L Grayson; R Lucas; B Dwyer
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

Review 4.  Diagnosis of deep-vein thrombosis.

Authors: 
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

5.  The effects of the AIDS epidemic on the tuberculosis problem and tuberculosis programmes.

Authors:  G Slutkin; J Leowski; J Mann
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1988-06

6.  Interaction of ketoconazole with rifampin and isoniazid.

Authors:  D Engelhard; H R Stutman; M I Marks
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

7.  Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

Authors:  J Chiu; J Nussbaum; S Bozzette; J G Tilles; L S Young; J Leedom; P N Heseltine; J A McCutchan
Journal:  Ann Intern Med       Date:  1990-09-01       Impact factor: 25.391

8.  Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.

Authors:  P Nunn; D Kibuga; S Gathua; R Brindle; A Imalingat; K Wasunna; S Lucas; C Gilks; M Omwega; J Were
Journal:  Lancet       Date:  1991-03-16       Impact factor: 79.321

9.  Drug interactions with fluconazole.

Authors:  J D Lazar; K D Wilner
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

10.  Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.

Authors:  P M Small; G F Schecter; P C Goodman; M A Sande; R E Chaisson; P C Hopewell
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245
View more
  2 in total

Review 1.  Pharmacokinetic factors in the modern drug treatment of tuberculosis.

Authors:  J G Douglas; M J McLeod
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

Review 2.  Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.

Authors:  M Barry; S Gibbons; D Back; F Mulcahy
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.